dr. W.J. Plattel

No picture available
E-mail:
w.j.plattel umcg.nl

Research

  1. 2020
  2. Reedijk, A. M. J., Zijtregtop, E. A. M., Coebergh, J. W. W., Meyer-Wentrup, F. A. G., Hebeda, K. M., Zwaan, C. M., Janssens, G. O. R., Pieters, R., Plattel, W. J., Dinmohamed, A. G., Zijlstra, J. M., Kremer, L. C. M., Lugtenburg, P. J., Beishuizen, A., & Karim-Kos, H. E. (2020). Improved survival for adolescents and young adults with Hodgkin lymphoma and continued high survival for children in the Netherlands: a population-based study during 1990-2015. British Journal of Haematology, 189(6), 1093-1106. https://doi.org/10.1111/bjh.16491
  3. Kersten, M. J., Driessen, J., Zijlstra, J. M., Plattel, W. J., Morschhauser, F., Lugtenburg, P. J., Brice, P., Hutchings, M., Gastinne, T., Liu, R., Burggraaff, C. N., Nijland, M., Tonino, S. H., Arens, A. I. J., Valkema, R., van Tinteren, H., Lopez-Yurda, M., Diepstra, A., De Jong, D., & Hagenbeek, A. (2020). Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transplant BRaVE study. Haematologica. https://doi.org/10.3324/haematol.2019.243238
  4. 2019
  5. 2017
  6. 2016
  7. 2014
  8. 2013
  9. 2012
  10. 2011

ID: 273122